radiotherapy. Brachytherapy uses
an active radiation source to deliver the dose of radiotherapy either inserted into the tumour directly
|
RADIOTHERAPY INTENT AND RATIONALE
THE intent, rationale, schedule, dose
|
|||||||
or into a body cavity. There are two |
and fractionation of radiotherapy are |
|||||||
main types of brachytherapy. In the |
decided after consideration of several |
|||||||
first, called low dose rate brachyther- |
factors( see box 2). |
|||||||
apy, the source is inserted into the |
Treatment intent is a significant |
|||||||
organ permanently. This is most |
factor, with higher doses and more |
|||||||
commonly used to treat prostate |
treatments( fractions) prescribed over |
|||||||
cancer. Once inserted, the source is |
several weeks in the curative setting. |
|||||||
not a radiation risk, as the distance the radiation travels in the body is |
This is to deliver the highest tolerable dose to eradicate the tumour, while |
|||||||
small and the source decays over |
accepting some short-term toxicities |
|||||||
time. The second is called high dose |
and minimal late toxicities. Lower |
|||||||
rate brachytherapy, where the source |
doses and shorter courses of treatment |
|||||||
is inserted and then removed. This |
are recommended in the palliative set- |
|||||||
technique poses additional radiation |
ting; this is to deliver a dose to achieve |
|||||||
safety issues, as the source cannot |
symptom control and minimise the |
|||||||
be turned‘ off’ but can be placed in a |
patient’ s time away from home. There |
|||||||
shielded safe when not required. |
are generally fewer side effects with |
|||||||
A key principle of radiotherapy |
the lower dose and shorter course. |
|||||||
is that while individual cells cannot |
Significant late toxicity, regardless of |
|||||||
be targeted, they can essentially be selected through a process of fractionation. This describes dividing up the total course of radiotherapy |
Figure 2. More accurate planning for radiotherapy using visualised soft tissue structures. |
intent, is undesirable.
The radiation dose delivered to the patient in the treatment setting is in a unit known as the gray( Gy). Most
|
||||||
over a number of days / weeks. When |
curative schedules of radiotherapy |
|||||||
the radiation is delivered, the cancer |
are delivered at 2Gy / day five days per |
|||||||
cell is likely to have defective DNA |
week, a total dose of about 50-70Gy. |
|||||||
repair and is therefore destroyed. |
Some tumour sites, such as head / neck |
|||||||
Normal cells are expected to have |
cancer, require a higher dose of 70Gy, |
|||||||
normal DNA repair and can there- |
while a localised low-grade lymphoma |
|||||||
fore heal between each fraction of |
requires a dose of 24Gy. |
|||||||
radiotherapy. |
In the palliative setting, higher |
|||||||
Fractionation also aids poten- |
doses of radiotherapy are delivered |
|||||||
tial redistribution of cells in the cell |
per fraction to decrease the overall |
|||||||
cycle to a more radiosensitive phase. |
treatment time burden for the patient |
|||||||
The oxygenation status of a tumour |
and because a higher total dose is not |
|||||||
is also an important predictor of |
required, as total tumour eradication |
|||||||
response to radiotherapy; the more |
is not the intent. |
|||||||
oxygenated the tumour, the greater |
Safe delivery of radiation ther- |
|||||||
the DNA damage from radiotherapy. |
apy requires a multidisciplinary team |
|||||||
Fractionation improves this by pro- |
approach, including radiation oncolo- |
|||||||
gressively shrinking the tumour to |
gists, medical physicists and radiation |
|||||||
improve oxygenation. Transiently |
therapists. The radiation oncologist |
|||||||
open blood vessels may also be more likely to be open over multiple fractions of radiotherapy as opposed to a single treatment. Repopulation of both cancerous and normal tissue occurs, so treatment breaks are |
Figure 3. Multiple small beams of radiation can be shaped by the treating machine to create a more conformal dose distribution. |
assesses the patient and prescribes the radiotherapy; the physicist ensures the prescribed radiation dose is being delivered correctly by the machines; and the radiation therapist positions the patient and ensures the accurate |
||||||
generally avoided unless the patient |
delivery of treatment. The role of the |
|||||||
experiences significant toxicities. |
excision, and is non-invasive com- |
of modalities to achieve an optimal |
dications to radiotherapy, although |
physicist is especially important, as |
||||
INDICATIONS AND CONTRA INDICATIONS
UNLIKE other cancer therapies,
|
pared with surgical resection. For these reasons, radiotherapy is estimated to be of benefit in about 50 % of patients with cancer. 4
Most tumours can be treated with
|
outcome.
The decision to use radiotherapy for a particular cancer is made by a multidisciplinary team. Team meetings are based around tumour sub-
|
retreatment of previously irradiated tissue needs to be performed with caution. This is because previously irradiated tissue will retain some irreversible tissue effects from the |
radiation cannot be seen or sensed.
WHAT CAN A PATIENT EXPECT?
SEVERAL steps are followed before
|
||||
radiotherapy can be used to treat |
radiotherapy either on its own( defin- |
types, and a range of professionals, |
radiotherapy. The benefit of radio- |
a patient starts with radiation therapy. |
||||
tumours from the vertex of the scalp |
itively) or in conjunction with surgi- |
including surgeons, pathologists, |
therapy is always weighed up against |
This multi-step planning process takes |
||||
all the way to the tip of the toe. It |
cal resection, chemotherapy, targeted |
radiologists, radiation oncologists, |
the risks, as with any other medical |
time, so it may be a while before the |
||||
has the advantages of not being lim- |
therapy, immunotherapy or hor- |
medical oncologists and allied health |
procedure. |
patient starts treatment. In emergency |
||||
ited by the blood brain barrier or by |
mone therapy( adjuvantly). Many |
staff, will attend. |
The indications for radiotherapy |
cases, this process may occur on the |
||||
structures that may impair surgical |
cancer types require a combination |
There are no absolute contrain- |
appear in box 1. |
same day, but a wait of several weeks |